z-logo
open-access-imgOpen Access
CERTOLIZUMAB PEGOL IN PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED EFFICACY ANALYSIS OF PHASE 3 CLINICAL TRIALS ACROSS BASELINE RHEUMATOID FACTOR QUARTILES
Author(s) -
Ricardo Machado Xavier,
Yoshiya Tanaka,
Zhanguo Li,
Nevsun İnanç,
Nicola Tilt,
Carlos Cara,
Carine Saadoun,
Tsutomu Takeuchi
Publication year - 2021
Publication title -
anais do congresso brasileiro de reumatologia 2020
Language(s) - English
Resource type - Conference proceedings
DOI - 10.47660/cbr.2020.17164
Subject(s) - certolizumab pegol , rheumatoid arthritis , medicine , quartile , rheumatoid factor , clinical trial , adalimumab , confidence interval

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom